The 92 references in paper O. Pylaeva A., A. Shatenshtein A., K. Mukhin Yu., О. Пылаева А., А. Шатенштейн А., К. Мухин Ю. (2018) “Синдром дефицита внимания и гиперактивности: сопутствующие заболевания, акцент на сочетание с эпилепсией // Attention deficit hyperactivity disorder: concomitant diseases with an emphasis on epilepsy” / spz:neicon:rjdn:y:2018:i:3:p:57-73

1
Брязгунов И.П., Гончарова О.В., Касатикова Е.В. Синдром дефицита внимания с гиперактивностью у детей: протокол лечения. Российский педиатрический журнал 2001;5:34–6. [Bryazgunov I.P., Goncharova O.V., Kasatikova E.V. Attention deficit hyperactivity disorder: treatment protocol. Rossiyskiy pediatricheskiy zhurnal = Russian Pediatric Journal 2001;5:34–6. (In Russ.)].
(check this in PDF content)
2
Воронкова К.В., Петрухин А.С. Нарушения когнитивных функций у больных с эпилепсией, возможности профилактики и коррекции: современное состояние проблемы. Эффективная фармакология. 2011;4:46–51. [Voronkova K.V., Petrukhin A.S. Cognitive impairments in patients with epilepsy, their prevention and treatment: current concepts. Effekktivnaya farmakologiya = Effective Pharmacology. 2011;4:46–51. (In Russ.)].
(check this in PDF content)
3
Заваденко Н.Н., Симашкова Н.В. Новые подходы к диагностике синдрома дефицита внимания и гиперактивности. Журнал неврологии и психиатрии им. С.С. Корсакова 2014;114(1 выпуск 2): 45–51. [Zavadenko N.N., Simashkova N.V. New approaches to the diagnosis of attention deficit hyperactivity disorder. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry 2014;114(1st issue 2):45–51. (In Russ.)].
(check this in PDF content)
4
Заваденко Н.Н., Соломасова А.А. Синдром дефицита внимания с гиперактивностью в сочетании с тревожными расстройствами: возможности фармакотерапии. Журнал неврологии и психиатрии им. С.С. Корсакова 2012;112(8):44–8. [Zavadenko N.N., Solomasova A.A. Combination of attention deficit hyperactivity disorder and anxiety disorders: pharmacotherapy options. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry 2012;112(8):44–8. (In Russ.)].
(check this in PDF content)
5
Зенков Л.Р., Константинов П.А., Ширяева И.Ю. и др. Психические и поведенческие расстройства при идиопатических эпилептиформных фокальных разрядах. Журнал неврологии и психиатрии им. С. С. Корсакова 2007; 107(6):39–49. [Zenkov L.R., Konstantinov P.A., Shiryaeva I.Yu. et al. Mental and behavioral disorders in patients with idiopathic focal epileptiform discharges. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry 2007;107(6):39–49. (In Russ.)].
(check this in PDF content)
6
Зыков В.П., Бегашева О.И. Современные концепции диагностики и опыт лечения гопантеновой кислотой синдрома дефицита внимания с гиперактивностью. Педиатрия (прил. к журналу Consilium Medicum) 2017;1:114–8. [Zykov V.P., Begasheva O.I. Current concepts in the diagnosis of attention deficit hyperactivity disorder and experience of its treatment with hopantenic acid. Pediatriya = Pediatrics (annex to the journal Consilium Medicum) 2017;1:114–8. (In Russ.)].
(check this in PDF content)
7
Зыков В.П., Каширина Э.С., Наугольных Ю.В. Методы объективного контроля эффективности терапии у детей с тиками. Неврологический вестник. Журнал им. В.М. Бехтерева 2016;2: 35–41. [Zykov V.P., Kashirina E.S., Naugolnykh Yu.V. Objective methods for evaluating the efficacy of treatment in children with tics. Nevrologicheskiy vestnik. Zhurnal im. V.M. Bekhtereva = Neurological Bulletin. V.M. Bekhterev Journal 2016;2:35–41. (In Russ.)].
(check this in PDF content)
8
Карлов В.А. Эпилепсия у детей и взрослых женщин и мужчин. М.: Медицина, 2010. С. 543–562. [Karlov V.A. Epilepsy in children and adult men and women. Moscow: Meditsina, 2010. Pp. 543–562. (In Russ.)].
(check this in PDF content)
9
Муратова Н.В. Пантокальцин®: области клинического применения. Русский медицинский журнал 2007;10:868. [Muratova N.V. Pantocalcin®: clinical applications. Russian Medical Journal 2007;10:868. (In Russ.)].
(check this in PDF content)
10
Мусатова Н.М. Пантокальцин в лечении синдрома гиперактивности и дефицита внимания. Трудный пациент 2006;4(6):2–3. [Musatova N.P. Pantocalcin in the treatment of attention deficit hyperactivity disorder. Trudnyy patsient = Difficult Patient 2006;4(6):2–3. (In Russ.)].
(check this in PDF content)
11
Мухин К.Ю., Глухова Л.Ю., Бобыло- ва М.Ю. и др. Эпилептические синдромы. Диагностика и терапия. 4-е изд. М.: «Бином», 2018. 607 c. [Mukhin K. Yu., Glukhova L.Yu., Bobylova M.Yu. et al. Epileptic syndromes: diagnosis and treatment. 4th edn. Moscow: “Binom”, 2018. 607 p. (In Russ.)].
(check this in PDF content)
12
Пылаева О.А., Мухин К.Ю., Петру- хин А.С. Побочные эффекты антиэпилептической терапии. М.: Гранат, 2016. 232 с. [Pylaeva O.A., Mukhin K.Yu., Petrukhin A.S. Side effects of antiepileptic medication. Moscow: Granat, 2016. 232 p. (In Russ.)].
(check this in PDF content)
13
Пылаева О.А., Воронкова К.В., Петрухин А.С. Эффективность и безопасность антиэпилептической терапии у детей (сравнительная оценка препаратов вальпроевой кислоты и барбитуратов). Журнал неврологии и психиатрии им. С.С. Корсакова 2004;8:61–5. [Pylaeva O.A., Voronkova K.V., Petrukhin A.S. Efficacy and safety of antiepileptic therapy in children (comparison of valproic acid and barbiturates). Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry 2004;8:61–5. (In Russ.)].
(check this in PDF content)
14
Тумашенко А.Ф. Эффективность Пантокальцина в лечении синдрома дефицита внимания с гиперактивностью у детей и подростков. Педиатрия (прил. к журналу Consilium Medicum) 2006;2:56–8. [Tumashenko A.F. Efficacy of Pantocalcin in the treatment of attention deficit hyperactivity disorder in children and adolescents. Pediatriya = Pediatrics (annex to the journal Consilium Medicum) 2006;2:56–8. (In Russ.)].
(check this in PDF content)
15
Холин А.А., Ильина Е С. Сочетание эпилепсии с синдромом дефицита внимания и гиперактивности (клинические примеры). Вестник эпилептологии 2011;1:16–22. [Kholin A.A., Ilyina E.S. Combination of epilepsy and attention deficit hyperactivity disorder (case reports). Vestnik epileptologii = Bulletin of Epileptology 2011;1:16–22. (In Russ.)].
(check this in PDF content)
16
Aldenkamp A., Besag F., Gobbi G. et al. Psychiatric and behavioural disorders in children with epilepsy (ILAE Task Force Report): adverse cognitive and behavioural effects of antiepileptic drugs in children. Epileptic Disord 2016. PMID: 27184878. DOI: 10.1684/epd.2016.0817.
(check this in PDF content)
17
Aldenkamp A.P., Arzimanoglou A., Reijs R., van Mil S. Optimizing therapy of seizures in children and adolescents with ADHD. Neurology 2006;67(12 Suppl 4):49–51. PMID: 17190923.
(check this in PDF content)
18
Altunel A., Sever A., Altunel E.Ö. ACTH has beneficial effects on stuttering in ADHD and ASD patients with ESES: A retrospective study. Brain Dev 2017;39(2):130–7. PMID: 27645286. DOI: 10.1016/j.braindev.2016.09.001.
(check this in PDF content)
19
American Psychiatric Association. DSM-5 Task Force. Diagnostic and Statistical Manual of Mental Disorders DSM-5. 5th edn. Washington, DC: American Psychiatric Association, 2013.
(check this in PDF content)
20
Barabas G., Matthews W. S. Barbiturate anticonvulsants as a cause of severe depression. Pediatrics 1988;82:284–5. PMID: 3399308.
(check this in PDF content)
21
Barkley R.A. Attention-deficit hyperactivity disorder. Sci Am 1998;279(3):66–71. PMID: 9725940.
(check this in PDF content)
22
Becker K., Sinzig J.K., Holtmann M. Attention deficits and subclinical epileptiform discharges: are EEG diagnostics in ADHD optional or essential? Dev Med Child Neurol 2004;46(6):431–2. PMID: 15174538.
(check this in PDF content)
23
Ben-Ari Y. GABA excites and sculpts immature neurons well before delivery: modulation by GABA of the development of ventricular progenitor cells. Epilepsy Curr 2007;7(6):167–9. DOI: 10.1111/j.1535-7511.2007.00214.x.
(check this in PDF content)
24
Bertelsen E.N., Larsen J.T., Petersen L. et al. Epilepsy, febrile seizures, and subsequent risk of ADHD. Pediatrics 2016;138(2). PII: e20154654. DOI: 10.1542/peds.2015-4654.
(check this in PDF content)
25
Besag F., Gobbi G., Caplan R. et al. Psychiatric and behavioural disorders in children with epilepsy (ILAE Task Force Report): epilepsy and ADHD. Epileptic Disord 2016. PMID: 27210536.
(check this in PDF content)
26
Brown R.T., Freeman W.S., Perrin J.M. et al. Prevalence and assessment of attention-deficit/hyperactivity disorder in primary care settings. Pediatrics 2001;107(3):E43.
(check this in PDF content)
27
Caplan R. ADHD in pediatric epilepsy: fact or fiction? Epilepsy Curr 2017;17(2):93–5. DOI: 10.5698/15357511.17.2.93.
(check this in PDF content)
28
Caplan R., Siddarth P., Stahl L. et al. Childhood absence epilepsy: Behavioral, cognitive, and linguistic comorbidities. Epilepsia 2008;49(11):1838–46. PMID: 18557780. DOI: 10.1111/j.1528-1167.2008.01680.x.
(check this in PDF content)
29
Cardenas J.F., Rho J.M., Ng Y.T. Reversible lamotrigine-induced neurobehavioral disturbances in children with epilepsy. J Child Neurol 2010;25:182–7.
(check this in PDF content)
30
Chadwick D., Marson T. Choosing a first drug treatment for epilepsy after SANAD: randomized controlled trials, systematic reviews, guidelines and treating patients. Epilepsia 2007;48(7):1259–63. PMID: 17442006. DOI: 10.1111/j.1528-1167.2007.01086.x.
(check this in PDF content)
31
Cramer J.A., Hammer A.E., Kustra R.P. Improved mood states with lamotrigine in patients with epilepsy. Epilepsy Behav 2004;5(5):702–7. PMID: 15380122. DOI: 10.1016/j.yebeh.2004.07.005.
(check this in PDF content)
32
D’Agati E., Moavero R., Cerminara C., Curatolo P. Attention-deficit hyperactivity disorder (ADHD) and tuberous sclerosis complex. J Child Neurol 2009;24(10):1282–7.
(check this in PDF content)
33
Davis S.M., Katusic S.K., Barbaresi W.J. et al. Epilepsy in children with attentiondeficit/hyperactivity disorder. Pediatr Neurol 2010;42(5):325–30. PMID: 20399385. DOI: 10.1016/j.pediatrneurol.2010.01.005.
(check this in PDF content)
34
Vries P.J., Gardiner J., Bolton P.F. Neuropsychological attention deficits in tuberous sclerosis complex (TSC). Am J Med Genet A 2009;149A(3):387–95. PMID: 19215038. DOI: 10.1002/ ajmg.a.32690.
(check this in PDF content)
35
Depositario-Cabacar D.F., Zelleke T.G. Treatment of epilepsy in children with developmental disabilities. Dev Disabil Res Rev 2010;16(3):239–47. PMID: 20981762. DOI: 10.1002/ddrr.116.
(check this in PDF content)
36
Duane D.D. Increased frequency of rolandic spikes in ADHD children. Epilepsia 2004;45(5):564–5. PMID: 15101844. DOI: 10.1111/j.0013-9580.2004.t01-4-62803.x.
(check this in PDF content)
37
Dunn D.W., Austin J.K., Harezlak J., Ambrosius W.T. ADHD and epilepsy in childhood. Dev Med Child Neurol 2003;45(1):50–4. PMID: 12549755.
(check this in PDF content)
38
Dunn D.W., Kronenberger W.G. Childhood epilepsy, attention problems, and ADHD: review and practical considerations. Semin Pediatr Neurol 2005;12(4):222–8.
(check this in PDF content)
39
Dussaule C., Bouilleret V. Psychiatric effects of antiepileptic drugs in adults. Geriatr Psychol Neuropsychiatr Vieil 2018;16(2):181–8. DOI: 10.1684/ pnv.2018.0733.
(check this in PDF content)
40
Fernandez-Mayoralas D.M., FernándezJaén A., Muñoz-Jareño N. et al. Effectiveness of levetiracetam in a patient with chronic motor tics, Rolandic epilepsy and attentional and behavioural disorder. Rev Neurol 2009;49(9):502–3.
(check this in PDF content)
41
Gertrude H. ADHD as a risk factor for incident unprovoked seizures and epilepsy in children. Arch Gen Psychiatry 2004;61(7):731–6.
(check this in PDF content)
42
Glauser T.A., Cnaan A., Shinnar S. et al. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. N Engl J Med 2010:362;790–9.
(check this in PDF content)
43
Gonzalez-Heydrich J., Dodds A., Whit - ney J. et al. Psychiatric disorders and behavioral characteristics of pediatric patients with both epilepsy and attention-deficit hyperactivity disorder. Epilepsy Behav 2007;10(3):384–8.
(check this in PDF content)
44
Hamoda H.M., Guild D.J., Gumlak S. et al. Association between attention-deficit/hyperactivity disorder and epilepsy in pediatric populations. Expert Rev Neurother 2009;9(12):1747–54.
(check this in PDF content)
45
Hechtman L., Weiss G. Long-term outcome of hyperactive children. Am J Orthopsychiatry 1983;53(3):532–41.
(check this in PDF content)
46
Heil S.H., Holmes H.W., Bickel W.K. et al. Comparison of the subjective, physiological, and psychomotor effects of atomo xetine and methylphenidate in light drug users. Drug Alcohol Depend 2002;67(2):149–56.
(check this in PDF content)
47
Hemmer S.A., Pasternak J.F., Zecker S.G., Trommer B.L. Stimulant therapy and seizure risk in children with ADHD. Pediatr Neurol 2001;24(2): 99–102.
(check this in PDF content)
48
Hermann B., Jones J., Dabbs K. et al. The frequency, complications and aetiology of ADHD in new onset paediatric epilepsy. Brain 2007;130(Pt 12):3135–48.
(check this in PDF content)
49
Hesdorffer D.C., Ludvigsson P., Olafsson E. et al. ADHD as a risk factor for incident unprovoked seizures and epilepsy in children. Arch Gen Psychiatry 2004;61(7):731–6.
(check this in PDF content)
50
Ibekwe R.C., Chidi N.A., Ebele A.A., Chinyelu O.N. Comorbidity of attention deficit Hyperactivity Disorder (ADHD) and epilepsy in children seen In University of Nigeria Teaching Hospital Enugu: prevalence, clinical and social correlates. Niger Postgrad Med J 2014;21(4):273–8.
(check this in PDF content)
51
Inaba Y., Seki C., Ogiwara Y. et al. Supplementary motor area epilepsy associated with ADHD in an abused history. No To Hattatsu 2000;32(5):435–9.
(check this in PDF content)
52
Kaminow L., Schimschock J.R., Ham- mer A.E., Vuong A. Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy. Epilepsy Behav 2003;4(6):659–66.
(check this in PDF content)
53
Kang S.H., Yum M.S., Kim E.H. et al. Cognitive function in childhood epilepsy: importance of attention deficit hyperactivity disorder. J Clin Neurol 2015;11(1): 20–5. DOI: 10.3988/jcn.2015.11.1.20.
(check this in PDF content)
54
Kanner A.M. The use of psychotropic drugs in epilepsy: what every neurologist should know. Semin Neurol 2008;28(3):379–88.
(check this in PDF content)
55
Kartal A., Aksoy E., Deda G. The effects of risk factors on EEG and seizure in children with ADHD. Acta Neurol Belg 2017;117(1):169–73.
(check this in PDF content)
56
Kaufmann R., Goldberg-Stern H., Shuper A. Attention-deficit disorders and epilepsy in childhood: incidence, causative relations and treatment possibilities. J Child Neurol 2009;24(6):727–33.
(check this in PDF content)
57
Kinney R.O., Shaywitz B.A., Shaywitz S.E. et al. Epilepsy in children with attention deficit disorder: cognitive, behavioral, and neuroanatomic indices. Pediatr Neurol 1990;6(1):31–7.
(check this in PDF content)
58
Koneski J.A., Casella E.B. Attention deficit and hyperactivity disorder in people with epilepsy: diagnosis and implications to the treatment. Arq Neuropsiquiatr 2010;68(1):107–14.
(check this in PDF content)
59
Kral M.C., Lally M.D., Boan A.D. Identification of ADHD in youth with epilepsy. J Pediatr Rehabil Med 2016;9(3):223–9.
(check this in PDF content)
60
Kwan P., Brodie M.J. Neuropsychological effects of epilepsy and antiepileptic drugs. Lancet 2001;357(9251):216–22.
(check this in PDF content)
61
Laporte N., Sebire G., Gillerot Y. et al. Cognitive epilepsy: ADHD related to focal EEG discharges. Pediatr Neurol 2002;27(4):307–11.
(check this in PDF content)
62
Lehmkuhl G., Sevecke K., Frohlich J., Dopfner M. Child is inattentive, cannot sit still, disturbs the classroom. Is it really a hyperkinetic disorder? MMW Fortschr Med 2002;144(47):26–31.
(check this in PDF content)
63
Liu S.T., Tsai F.J., Lee W.T. et al. Attentional processes and ADHD-related symptoms in pediatric patients with epilepsy. Epilepsy Res 2011;93(1):53–65.
(check this in PDF content)
64
Marson A.G., Al-Kharusi A.M., Alwaidh M. et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007;369(9566):1000–15.
(check this in PDF content)
65
Moavero R., Santarone M.E., Galasso C., Curatolo P. Cognitive and behavioral effects of new antiepileptic drugs in pediatric epilepsy. Brain Dev 2017;39(6):464–9. DOI: 10.1016/j.braindev.2017.01.006.
(check this in PDF content)
66
Mula M., Sander J.W. Negative effects of antiepileptic drugs on mood in patients with epilepsy. Drug Saf 2007;30(7): 555–67.
(check this in PDF content)
67
Mulas F., Tellez de Meneses M., Hernandez-Muela S. et al. Attention deficit hyperactivity disorder and epilepsy. Rev Neurol 2004;39(2):192–5.
(check this in PDF content)
68
Neto F.K., Noschang R., Nunes M.L. The relationship between epilepsy, sleep disorders, and attention deficit hyperactivity disorder (ADHD) in children: A review of the literature. Sleep Sci 2016;9(3): 158–63.
(check this in PDF content)
69
Ott D., Caplan R., Guthrie D. et al. Measures of psychopathology in children with complex partial seizures and primary generalized epilepsy with absence. J Am Acad Child Adolesc Psychiatry 2001;40:907–14.
(check this in PDF content)
70
Ottman R., Lipton R.B., Ettinger A.B. et al. Comorbidities of epilepsy: Results from the Epilepsy Comorbidities and Health (EPIC) Survey. Epilepsia 2011;52(2):308–15. DOI: 10.1111/j.1528-1167.2010.02927.x.
(check this in PDF content)
71
Parisi P., Moavero R., Verrotti A., Curatolo P. Attention deficit hyperactivity disorder in children with epilepsy. Brain Dev 2010;32(1):10–6. PMID: 19369016. DOI: 10.1016/j.braindev.2009.03.005.
(check this in PDF content)
72
Pearl P.L., Weiss R.E., Stein M.A. Medical mimics. Medical and neurological conditions simulating ADHD. Ann N Y Acad Sci 2001;931:97–112. PMID: 11462759.
(check this in PDF content)
73
Powell A.L., Yudd A., Zee P., Mandelbaum D.E. Attention deficit hyperactivity disorder associated with orbitofrontal epilepsy in a father and a son. Neuropsychiatry Neuropsychol Behav Neurol 1997;10(2):151–4.
(check this in PDF content)
74
Rasmussen N.H., Hansen L.K., Sahlholdt L. Comorbidity in children with epilepsy. I: Behaviour problems, ADHD and intelligence. Ugeskr Laeger 2007;169(19): 1767–70. PMID: 17537348.
(check this in PDF content)
75
Rugino T.A., Samsock T.C. Levetiracetam in autistic children: an open-label study. J Dev Behav Pediatr 2002;23(4):225–30.
(check this in PDF content)
76
Schubert R. Attention deficit disorder and epilepsy. Pediatr Neurol 2005;32(1):1–10.
(check this in PDF content)
77
Seidenberg M., Pulsipher D.T., Hermann B. Association of epilepsy and comorbid conditions. Future Neurol 2009;4(5):663–8. PMID: 20161538. DOI: 10.2217/fnl.09.32.
(check this in PDF content)
78
Semrud-Clikeman M., Wical B. Components of attention in children with complex partial seizures with and without ADHD. Epilepsia 1999;40(2):211–5. PMID: 9952269.
(check this in PDF content)
79
Sherman E.M., Slick D.J., Connolly M.B., Eyrl K.L. ADHD, neurological correlates and health-related quality of life in severe pediatric epilepsy. Epilepsia 2007;48(6):1083–91. PMID: 17381442. DOI: 10.1111/j.1528-1167.2007.01028.x.
(check this in PDF content)
80
Sinclair D.B., Unwala H. Absence epilepsy in childhood: electroencephalography (EEG) does not predict outcome. J Child Neurol 2007;22(7):799–802. PMID: 17715268. DOI: 10.1177/0883073807304198.
(check this in PDF content)
81
Sinzig J.K., von Gontard A. Absences as differential diagnosis in children with attention-deficit disorder. Klin Padiatr 2005;217(4):230–3. PMID: 16032549. DOI: 10.1055/s-2004-820328.
(check this in PDF content)
82
Socanski D., Herigstad A., Thomsen P.H. et al. Epileptiform abnormalities in children diagnosed with attention deficit/hyperactivity disorder. Epilepsy Behav 2010;19(3):483–6. PMID: 20869322. DOI: 10.1016/j.yebeh.2010.08.005.
(check this in PDF content)
83
Torres A., Whitney J., Rao S. et al. Tolerability of atomoxetine for treatment of pediatric attention-deficit/hyperactivity disorder in the context of epilepsy. Epilepsy Behav 2011;20(1):95–102. PMID: 21146461. DOI: 10.1016/j.yebeh.2010.11.002.
(check this in PDF content)
84
Torres A.R., Whitney J., Gonzalez-Heydrich J. Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment. Epilepsy Behav 2008;12(2):217–33. PMID: 18065271. DOI: 10.1016/j.yebeh.2007.08.001.
(check this in PDF content)
85
Feltz-Cornelis C.M., Aldenkamp A.P. Effectiveness and safety of methylphenidate in adult attention deficit hyperactivity disorder in patients with epilepsy: an open treatment trial. Epilepsy Behav 2006;8(3):659–62. PMID: 16504592. DOI: 10.1016/j.yebeh.2006.01.015.
(check this in PDF content)
86
Vega C., Vestal M., DeSalvo M. et al. Differentiation of attention-related problems in childhood absence epilepsy. Epilepsy Behav 2010;19(1):82–5.
(check this in PDF content)
87
Weinstock A., Giglio P., Kerr S.L. et al. Hyperkinetic seizures in children. J Child Neurol 2003;18(8):517–24. PMID: 13677576. DOI: 10.1177/08830738030180080801.
(check this in PDF content)
88
Wernicke J.F., Holdridge K.C., Jin L. et al. Seizure risk in patients with attention-deficit-hyperactivity disorder treated with atomoxetine. Dev Med Child Neurol 2007;49(7):498–502. PMID: 17593120. DOI: 10.1111/j.1469-8749.2007.00498.x.
(check this in PDF content)
89
Williams A.E., Giust J.M., Kronenber- ger W.G., Dunn D.W. Epilepsy and attention-deficit hyperactivity disorder: links, risks, and challenges. Neuropsychiatr Dis Treat 2016;12:287–96. DOI: 10.2147/ NDT.S81549.
(check this in PDF content)
90
Wisniewska B., Baranowska W., Wendorff J. The assessment of comorbid disorders in ADHD children and adolescents. Adv Med Sci 2007;52 (Suppl 1):215–7. PMID: 18229669.
(check this in PDF content)
91
Young J. Common comorbidities seen in adolescents with attention-deficit/hyperactivity disorder. Adolesc Med State Art Rev 2008;19(2):216–28.
(check this in PDF content)
92
Zhang Z., Lu G., Zhong Y. et al. Impaired attention network in temporal lobe epilepsy: a resting FMRI study. Neurosci Lett 2009;458(3):97–101. PMID: 19393717. DOI: 10.1016/j.ne
(check this in PDF content)